Moneycontrol PRO

you are here: HomeNewsBusinessStocksSee 10-15% upside in midcap pharma space: Vineet Bhatnagar

SHOW NAMES

Trending Topics

business

See 10-15% upside in midcap pharma space: Vineet Bhatnagar

Vineet Bhatnagar - MD at Phillip Capital expects 10-15 percent upside in midcap pharma stocks including Glenmark Pharma, Divis Laboratories, Torrent Pharma and Cadila Healthcare.

first published: Apr 16, 2015 11:43 am

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Live: Will Nifty continue its rangebound move this week? | Opening Bell
The Lawyer Renting in a 120-year-old building in South Mumbai | The Tenant
Nifty On Track To End Week Above 25,500 As Bank & Metal Stocks Lead Rebound| Closing Bell Live
Can Nifty Stage A Friday Fightback After Hitting 3-Week Low? Pine Labs IPO Opens | Opening Bell Live

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347